The Danish pharmaceutical company will reduce its 78,400-person workforce by approximately 9,000 positions to streamline operations and reinvest in diabetes and obesity drugs.
Original Image Link
Source:www.msn.com
Original Image Link
Source:www.msn.com
Posted: 2025-09-10 11:54:00